MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strassheim, D.
Right arrow Articles by Loh, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strassheim, D.
Right arrow Articles by Loh, H. H.

Vol. 53, Issue 6, 1047-1053, June 1998

Contribution of Phospholipase C-beta 3 Phosphorylation to the Rapid Attenuation of Opioid-Activated Phosphoinositide Response

Derek Strassheim, Ping-Yee Law, and Horace H. Loh

Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455-0347

Activation of the delta -opioid receptor in NG108-15 neuroblastoma X glioma hybrid cells results in a transient increase at the intracellular level of inositol-1,4,5-triphosphate [Ins(1,4,5)P3]. This time course in the transient increase in the Ins(1,4,5)P3 level is distinctly different from that observed in the homologous opioid receptor desensitization as measured by the inhibition of adenylyl cyclase activity. One probable mechanism for this rapid loss in Ins(1,4,5)P3 response is the feedback regulation of the phospholipase C activity. Regulation by protein phosphorylation was suggested by the observations that the opioid-mediated response was potentiated by calphostin C, an inhibitor of protein kinase C (PKC), and was abolished by either phorbol-12-myristate-13-acetate, a PKC activator, or calyculin A, a protein phosphatase1/2A inhibitor. The direct phosphorylation of phospholipase C was demonstrated by immunoprecipitation of PLC-beta 3 from metabolically labeled NG108-15 cells challenged with the delta -selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE). A time- and DPDPE concentration-dependent and naloxone-reversible increase in the PLC-beta 3 phosphorylation can be demonstrated. This PLC-beta 3 phosphorylation was mainly due to PKC activation because pretreatment of NG108-15 cells with calphostin C could block the DPDPE effect. Activation of the PLC-beta 3 by DPDPE was one of the prerequisites for agonist-mediated PLC-beta 3 phosphorylation because the aminosteroid phospholipase C inhibitor U73122 could block the DPDPE effect. In addition to DPDPE, lysophosphatidic acid (LPA) stimulated the PLC-beta 3 phosphorylation, but bradykinin did not. Furthermore, the LPA- and DPDPE-mediated PLC-beta 3 phosphorylation was additive and was much less than that observed with phorbol-12-myristate-13-acetate. The effect of DPDPE was specific to PLC-beta 3; the beta gamma -insensitive phospholipase C-beta 1 was not phosphorylated in the presence of either DPDPE or LPA. These results indicate that although PKC phosphorylation of PLC-beta 3 is not obligatory for the opioid receptor desensitization, it seems to play a significant facilatory role in the mechanisms allowing desensitization of opioid-activated phospholipase C response before that of adenylyl cyclase inhibition.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Cell Sci.Home page
R. Bhattacharya, J. Kwon, X. Li, E. Wang, S. Patra, J. P. Bida, Z. Bajzer, L. Claesson-Welsh, and D. Mukhopadhyay
Distinct role of PLC{beta}3 in VEGF-mediated directional migration and vascular sprouting
J. Cell Sci., April 1, 2009; 122(7): 1025 - 1034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Sakwe, L. Rask, and E. Gylfe
Protein Kinase C Modulates Agonist-sensitive Release of Ca2+ from Internal Stores in HEK293 Cells Overexpressing the Calcium Sensing Receptor
J. Biol. Chem., February 11, 2005; 280(6): 4436 - 4441.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y.-S. Oh, N. W. Jo, J. W. Choi, H. S. Kim, S.-W. Seo, K.-O. Kang, J.-I. Hwang, K. Heo, S.-H. Kim, Y.-H. Kim, et al.
NHERF2 Specifically Interacts with LPA2 Receptor and Defines the Specificity and Efficiency of Receptor-Mediated Phospholipase C-{beta}3 Activation
Mol. Cell. Biol., June 1, 2004; 24(11): 5069 - 5079.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Yuan, L. W. Slice, J. Gu, and E. Rozengurt
Cooperation of Gq, Gi, and G12/13 in Protein Kinase D Activation and Phosphorylation Induced by Lysophosphatidic Acid
J. Biol. Chem., February 7, 2003; 278(7): 4882 - 4891.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Piccoli, M. del Pilar Gomez, and E. Nasi
Role of protein kinase C in light adaptation of molluscan microvillar photoreceptors
J. Physiol., September 1, 2002; 543(2): 481 - 494.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Murthy, J. R. Grider, and G. M. Makhlouf
Heterologous desensitization of response mediated by selective PKC-dependent phosphorylation of Gi-1 and Gi-2
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C925 - C934.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. M. Samoriski and R. A. Gross
Functional Compartmentalization of Opioid Desensitization in Primary Sensory Neurons
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 500 - 509.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. H. Yoon, T.-M. Lo, H. H. Loh, and S. A. Thayer
delta -Opioid-Induced Liberation of Gbeta gamma Mobilizes Ca2+ Stores in NG108-15 Cells
Mol. Pharmacol., November 1, 1999; 56(5): 902 - 908.
[Abstract] [Full Text]


Home page
BloodHome page
M. G. Cifone, G. Migliorati, R. Parroni, C. Marchetti, D. Millimaggi, A. Santoni, and C. Riccardi
Dexamethasone-Induced Thymocyte Apoptosis: Apoptotic Signal Involves the Sequential Activation of Phosphoinositide-Specific Phospholipase C, Acidic Sphingomyelinase, and Caspases
Blood, April 1, 1999; 93(7): 2282 - 2296.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yue, C.-Y. Ku, M. Liu, M. I. Simon, and B. M. Sanborn
Molecular Mechanism of the Inhibition of Phospholipase C beta 3 by Protein Kinase C
J. Biol. Chem., September 22, 2000; 275(39): 30220 - 30225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Strassheim and C. L. Williams
P2Y2 Purinergic and M3 Muscarinic Acetylcholine Receptors Activate Different Phospholipase C-beta Isoforms That Are Uniquely Susceptible to Protein Kinase C-dependent Phosphorylation and Inactivation
J. Biol. Chem., December 8, 2000; 275(50): 39767 - 39772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Xu, Y. Wang, L. Y. Xu, and R. S. Gilmour
Protein Kinase C alpha -mediated Negative Feedback Regulation Is Responsible for the Termination of Insulin-like Growth Factor I-induced Activation of Nuclear Phospholipase C beta 1 in Swiss 3T3 Cells
J. Biol. Chem., April 27, 2001; 276(18): 14980 - 14986.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics